Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway

被引:64
作者
Shankar, P [1 ]
Xu, Z [1 ]
Lieberman, J [1 ]
机构
[1] Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA
关键词
D O I
10.1182/blood.V94.9.3084.421k02_3084_3093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cytotoxic T lymphocytes (CTL) lyse antigen-bearing target cells by two distinct pathways. Whereas granule exocytosis targets any antigen-bearing cell, fas-mediated cytotoxicity kills only fas-expressing cells and does not require antigen expression. Fas pathway activation can potentially lead to lysis of uninfected bystander cells. We examined the relative usage of the two pathways by CTL clones and cell lines directed against four different human immunodeficiency virus (HIV) proteins in lysing primary HIV-infected targets. Although fas was expressed on HIV-infected primary CD4(+) T cells, their lysis by antigen-specific CD8(+) CTL was only by the granule pathway. Fas ligand (fasL) was not detectable on antigen-specific CD8 clones, T-cell lines, or circulating HIV-specific CD8 T cells from HIV-infected donors, stained with a tetrameric HLA-AZ-HIV-peptide complex. Fast expression by HIV-specific CTL clones was not activated by exposure to HIV-presenting cells, but was after unphysiological stimulation with phorbol myristate acetate (PMA). CTL clones did not lyse bystander Jurkat cells, but HIV-infected primary CD4(+) T cells lysed uninfected bystander cells by the fas-mediated pathway. These results suggest that HIV-specific CD8(+) CTL do not cause HIV immunopathology by lysing bystander cells. On the contrary, fas-mediated lysis of uninfected cells by HIV-infected cells may contribute to CD4 decline. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:3084 / 3093
页数:10
相关论文
共 73 条
  • [1] TARGETED MUTATION IN THE FAS GENE CAUSES HYPERPLASIA IN PERIPHERAL LYMPHOID ORGANS AND LIVER
    ADACHI, M
    SUEMATSU, S
    KONDO, T
    OGASAWARA, J
    TANAKA, T
    YOSHIDA, N
    NAGATA, S
    [J]. NATURE GENETICS, 1995, 11 (03) : 294 - 300
  • [2] Phenotypic analysis of antigen-specific T lymphocytes
    Altman, JD
    Moss, PAH
    Goulder, PJR
    Barouch, DH
    McHeyzerWilliams, MG
    Bell, JI
    McMichael, AJ
    Davis, MM
    [J]. SCIENCE, 1996, 274 (5284) : 94 - 96
  • [3] MECHANISMS OF CLASS-I RESTRICTED IMMUNOPATHOLOGY - A TRANSGENIC MOUSE MODEL OF FULMINANT-HEPATITIS
    ANDO, K
    MORIYAMA, T
    GUIDOTTI, LG
    WIRTH, S
    SCHREIBER, RD
    SCHLICHT, HJ
    HUANG, SN
    CHISARI, FV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) : 1541 - 1554
  • [4] Ando K, 1997, J IMMUNOL, V158, P5283
  • [5] Two signaling pathways can lead to Fas ligand expression in CD8(+) cytotoxic T lymphocyte clones
    Anel, A
    Simon, AK
    Auphan, N
    Buferne, M
    Boyer, C
    Golstein, P
    SchmittVerhulst, AM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (12) : 3381 - 3387
  • [6] Macrophage-dependent apoptosis of CD4(+) T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor
    Badley, AD
    Dockrell, D
    Simpson, M
    Schut, R
    Lynch, DH
    Leibson, P
    Paya, CV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) : 55 - 64
  • [7] CROSS-LINKING CD4 BY HUMAN IMMUNODEFICIENCY VIRUS-GP120 PRIMES T-CELLS FOR ACTIVATION-INDUCED APOPTOSIS
    BANDA, NK
    BERNIER, J
    KURAHARA, DK
    KURRLE, R
    HAIGWOOD, N
    SEKALY, RP
    FINKEL, TH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) : 1099 - 1106
  • [8] BARNABA V, 1989, J IMMUNOL, V143, P2650
  • [9] Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients
    Bofill, M
    Mocroft, A
    Lipman, M
    Medina, E
    Borthwick, NJ
    Sabin, CA
    Timms, A
    Winter, M
    Baptista, L
    Johnson, MA
    Lee, CA
    Phillips, AN
    Janossy, G
    [J]. AIDS, 1996, 10 (08) : 827 - 834
  • [10] VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    BORROW, P
    LEWICKI, H
    HAHN, BH
    SHAW, GM
    OLDSTONE, MBA
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6103 - 6110